Lai-Shan Tam

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.

Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus.

Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.

Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.

Leflunomide in the treatment of rheumatoid arthritis.

Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.

Can the urine dipstick test reduce the need for microscopy for assessment of systemic lupus erythematosus disease activity?

The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.

Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis.

Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: clinical and magnetic resonance imaging evaluation.

Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.

Maintenance treatment of proliferative lupus nephritis can be discontinued after remission in some patients.

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis.

Intrarenal cytokine gene expression in lupus nephritis.

Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial.

Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study.

Are spot urine samples adequate for assessment of proteinuria in patients with lupus nephritis?

Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.

The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus.

Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund's complete adjuvant.

Subclinical carotid atherosclerosis in patients with psoriatic arthritis.

Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

Psoriatic arthritis in Asia.

The impact of flare on disease costs of patients with systemic lupus erythematosus.

The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.

Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study.

Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study.

Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus.

Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.

Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology.

Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis.

Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.

Cost-of-illness studies in systemic lupus erythematosus: A systematic review.

Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis.

Repeat renal biopsy in lupus nephritis: a change in histological pattern is common.

Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.

Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus.

Monitoring of urinary messenger RNA levels for the prediction of flare in systemic lupus erythematosus.

The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.

Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis.

Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.

Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.

Cardiovascular risk in patients with psoriatic arthritis.

Relationship of intrarenal gene expression and the histological class of lupus nephritis -- a study on repeat renal biopsy.

Increased organ damage associated with deterioration in volumetric bone density and bone microarchitecture in patients with systemic lupus erythematosus on longterm glucocorticoid therapy.

Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.

Increase in ventricular-arterial stiffness in patients with psoriatic arthritis.

Bone density and microarchitecture: relationship between hand, peripheral, and axial skeletal sites assessed by HR-pQCT and DXA in rheumatoid arthritis.

Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.

Structure and strength of the distal radius in female patients with rheumatoid arthritis: a case-control study.

Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.

Impaired left ventricular apical rotation is associated with disease activity of psoriatic arthritis.

Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case-control study with HR-pQCT.

Bone mineral density change in systemic lupus erythematosus: a 5-year followup study.

A pilot evaluation of Arthritis Self-Management Program by lay leaders in patients with chronic inflammatory arthritis in Hong Kong.

Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing.

IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study.

Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study.

Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.

Intrarenal and Urinary Th9 and Th22 Cytokine Gene Expression in Lupus Nephritis.

Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.

Authors' Reply to "Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases".

Infliximab in the treatment of refractory ocular inflammatory diseases.

Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial.

Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus.

Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis.

Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.

Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.

The Role of High-resolution Peripheral Quantitative Computed Tomography as a Biomarker for Joint Damage in Inflammatory Arthritis.

Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.

In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.

Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease.

Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.

Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis.

Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis.

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study.

The role of imaging in early diagnosis and prevention of joint damage in inflammatory arthritis.

Effect of Treat-to-target Strategies Aiming at Remission of Arterial Stiffness in Early Rheumatoid Arthritis: A Randomized Controlled Study.

Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study.

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study.

Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid Treatment.

Effect of Achieving Minimal Disease Activity on the Progression of Subclinical Atherosclerosis and Arterial Stiffness: A Prospective Cohort Study in Psoriatic Arthritis.

Dr. Tam, reply.

Clinical presentation, treatment and outcome of Takayasu's arteritis in southern Chinese: a multicenter retrospective study.

Comment on: Efficacy and safety of biologics targeting interleukin-6, -12/23 and -17 pathways for peripheral psoriatic arthritis: a network meta-analysis: reply.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Risk of tuberculosis in patients with immune-mediated diseases on biological therapies: a population-based study in a tuberculosis endemic region.

Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group.

2018 APLAR axial spondyloarthritis treatment recommendations.

ERAMRS: a new MR scoring system for early rheumatoid arthritis of the wrist.

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.

Imaging of sacroiliitis: Current status, limitations and pitfalls.

Authors reply to comment on axial SpA recommendations.

Circulating miR-99b-5p as a novel predictor of erosion progression on high-resolution peripheral quantitative computed tomography in early rheumatoid arthritis: A prospective cohort study.

Early phase and adaptive design clinical trials in rheumatoid arthritis: a systematic review of early phase trials.

Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.

Comparison of bone structure and microstructure in the metacarpal heads between patients with psoriatic arthritis and healthy controls: an HR-pQCT study.

Treat to target and prevention of subclinical atherosclerosis in psoriatic arthritis-which target should we choose?

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.

No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak.

Elevating the role of carers in rheumatoid arthritis management in the Asia-Pacific region.

DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.

Effect of biologics on radiographic progression of peripheral joint in patients with psoriatic arthritis: meta-analysis.

High-Resolution Peripheral Quantitative Computed Tomography for Bone Evaluation in Inflammatory Rheumatic Disease.

Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: A population-based study.

Comparison of carotid artery ultrasound and Framingham risk score for discriminating coronary artery disease in patients with psoriatic arthritis.

Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.

Risk of community-acquired pneumonia requiring hospitalization in patients with spondyloarthritis.

Gut Microbiome and Its Interaction with Immune System in Spondyloarthritis.

The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.

MRI wrist in early rheumatoid arthritis: reduction in inflammation assessed quantitatively during treatment period correlates best with clinical improvement.

Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017.

Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial.

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.

Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management.

Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.

Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.

Factors Associated With Use of Telemedicine for Follow-Up of SLE in the COVID-19 Outbreak.

The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study.

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis.

Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial.

Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus.

Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.

Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus.

Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases.

Serum Calprotectin Level Is Independently Associated With Carotid Plaque Presence in Patients With Psoriatic Arthritis.

Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.

Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis.

High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.

Spondyloarthritis: How far are we from precision medicine?

The Role of Imaging in Predicting the Development of Rheumatoid Arthritis.

Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies-A population-based study.

The temporal trend of disease burden attributable to metabolic risk factors in China, 1990-2019: An analysis of the Global Burden of Disease study.

Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.

A novel visceral adiposity index predicts bone loss in female early rheumatoid arthritis patients detected by HR-pQCT.

Automatic 3D joint erosion detection for the diagnosis and monitoring of rheumatoid arthritis using hand HR-pQCT images.

Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study.

Telemedicine for follow-up of systemic lupus erythematosus during the 2019 coronavirus pandemic: A pragmatic randomized controlled trial.

The impact of comorbidities in patients with spondyloarthritis.

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis.

Role of inflammatory burden and treatment on joint space width in psoriatic arthritis-a high-resolution peripheral quantitative computed tomography study.